1 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Executive summary. Am J Kidney Dis 2002; 39:S17-31.
2 National Institute for Health and Care Excellence. Chronic kidney disease: early identification and management of chronic kidney disease in adults in primary and secondary care. http://guidance.nice.org.uk/CG73.
3 National Institute for Health and Care Excellence. About the Quality and Outcomes Framework. www.nice.org.uk/aboutnice/qof/qof.jsp.
4 Moyer V. Screening for chronic kidney disease. US Preventive Services Task Force recommendation statement. Ann Intern Med 2012; 157:567-70.
5 Wetzels JFM, Kiemeney LA, Swinkels DW, Willems HL, den Heijer M. Age- and gender-specific reference values of estimated GFR in caucasians: the Nijmegen Biomedical Study. Kidney Int 2007; 72:632-7.
6 Winearls CG, Haynes R, Glassock R. CKD staging—evolution not revolution. Nefrologia 2010; 30:493-500.
7 Eriksen BO, Ingebretsen OC. In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression. Kidney Int 2007; 72:1242-8.
8 KDIGO clinical practice guidelines for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3(1). www.kdigo.org/clinical_practice_guidelines/pdf/CKD/
9 Hoy WE, Mathews JD, McCredie D, Pugsley DJ, Hayhurst BG, Rees M, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54:1296-304.
10 Hallan SI. Matsushita K, Sang Y, Mahmoodi B, Black C, et al. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:2349-60.
11 Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 2011; 80:17-28.
12 Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073-81.
13 National Kidney Foundation/KDIGO guideline for CKD classification and management. 2012. www.kdigo.org/clinical_practice_guidelines/CKD.php.
14 National Kidney Foundation. Kidney disease outcomes and quality initiative guidelines. Part 12. Acknowledgements. 2002. www.kidney.org/professionals/kdoqi/guidelines_ckd/p12_ack.htm.
15 Levey AS, Coresh J. Chronic kidney disease. Lancet 2012; 379:165-80.
16 Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 2003; 14(suppl 2):S131-8.
17 Nissenson AR, Pereira BJG, Collins AJ, Steinberg EP. Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization. Am J Kidney Dis 2001; 37:1177-83.
18 Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008; 23:1117-21.
19 Chronic kidney disease: management in general practice. 2nd ed. Kidney Health Australia, 2012.
20 Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, et al. Implementing KDOQI CKD definition and staging guidelines in southern California Kaiser Permanente. Am J Kidney Dis 2009; 53(suppl 3):S86-99.
21 Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157:471-81.
22 National Kidney Foundation. About chronic kidney disease. 2012 www.kidney.org/kidneydisease/aboutckd.cfm.
23 Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW.
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey BMJ 2006; 333:1047.
24 Spence D. Bad medicine: chronic kidney disease BMJ 2010; 340:c3188.
25 Fink HA, Ishani A, Taylor BC, Greer NL, MacDonald R, Rossini D, et al. Chronic kidney disease stages 1-3: screening, monitoring, and treatment. Comparative effectiveness reviews No 37. 2012. www.ncbi.nlm.nih.gov/books/NBK84564/.
26 Winearls CG, Glassock RJ. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011; 119(suppl 1):c2-4.
27 Crinson I, Gallagher H, ThomasN, de Lusignan, S. How ready is general practice to improve quality in chronic kidney disease? A diagnostic analysis. Br J Gen Pract 2010; 60:403-9.
28 National Kidney Foundation. Chronic kidney disease. www.kidney.org.uk/Medical-Info/ ckd-info/index.html.
29 De Boer IH. Chronic kidney disease—a challenge for all ages. JAMA 2012; 308:1-2.
30 Richard Lehman’s journal review. BMJ blog, 17 December, 2012. http://blogs.bmj.com/bmj/2012/12/17/richard-lehmans-journal-review-17-december-2012/.
31 O’Hare A. Measures to define chronic kidney disease. JAMA 2013; 309:1343.
32 Parikh NI, Hwang S, Larson MG, Levy D, Fox C. Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study) Am J Cardiol 2008; 102:47-53.
33 Di Angelantonio E, Chowdhury R, Sarwar N, AspelundT, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study BMJ 2010; 341:c4986
34 Drawz PE, Baraniuk S, Davis BR, Brown CD, Colon PJ, Cujyet AB, et al. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation. Am Heart J 2012; 164:925-31.e2.
35 Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey A, Salem DN, et al. Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med 2007; 120:552.e1-8.
36 Glassock RJ. Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 2010; 12:364-8.
37 Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey. Am J Kidney Dis 2003; 41:1-12.
38 Samal L, Liner J. The primary care perspective on routine urine dipstick screening to identify patients with albuminuria. Clin J Am Soc Nephrol 2013; 8:131-5.
39 Pickering T. Now we are sick: labeling and hypertension. J Clin Hypertens 2006; 8:57-60.
40 Phillips, LA, Donovan KL, Phillips AO. Renal quality outcomes framework and eGFR: impact on secondary care Q J Med 2009; 102:415.
41 Noble E, Johnson DW, Gray N, Hollett P, Hawley CM, Campbell SB, et al. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant 2008; 23:3845-50.
42 Den Hartog JR, Reese PP, Cizman B, Feldman HI. The costs and benefits of automatic estimated glomerular filtration rate reporting. Clin J Am Soc Nephrol 2009; 4:419-27.
ComentariosUsted debe estar registrado para expresar su opinión. Si ya es usuario de IntraMed o desea registrase como nuevo usuario, ingrese aquí